AU2001284790A1 - Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein - Google Patents

Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein

Info

Publication number
AU2001284790A1
AU2001284790A1 AU2001284790A AU8479001A AU2001284790A1 AU 2001284790 A1 AU2001284790 A1 AU 2001284790A1 AU 2001284790 A AU2001284790 A AU 2001284790A AU 8479001 A AU8479001 A AU 8479001A AU 2001284790 A1 AU2001284790 A1 AU 2001284790A1
Authority
AU
Australia
Prior art keywords
protein
tumorsuppressor
klf6
kruppel
therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284790A
Inventor
Scott Friedman
Karen Heath
Dan Li
John Martignetti
Goutham Narla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU2001284790A1 publication Critical patent/AU2001284790A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001284790A 2000-08-09 2001-08-09 Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein Abandoned AU2001284790A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22411100P 2000-08-09 2000-08-09
US60/224,111 2000-08-09
PCT/US2001/025046 WO2002012894A1 (en) 2000-08-09 2001-08-09 Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein

Publications (1)

Publication Number Publication Date
AU2001284790A1 true AU2001284790A1 (en) 2002-02-18

Family

ID=22839318

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284790A Abandoned AU2001284790A1 (en) 2000-08-09 2001-08-09 Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein

Country Status (4)

Country Link
EP (1) EP1332362A4 (en)
AU (1) AU2001284790A1 (en)
CA (1) CA2419064A1 (en)
WO (1) WO2002012894A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105330D0 (en) 2001-03-02 2001-04-18 Renovo Ltd Genetic testing
GB0307472D0 (en) * 2003-04-01 2003-05-07 Lorantis Ltd Medical treatment
EP1794322A4 (en) * 2004-07-30 2009-10-28 Sinai School Medicine Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
EP2207555B1 (en) * 2007-10-05 2013-07-24 InDex Pharmaceuticals AB Oligonucleotides for the treatment or alleviation of edema

Also Published As

Publication number Publication date
WO2002012894A1 (en) 2002-02-14
EP1332362A4 (en) 2006-07-05
EP1332362A1 (en) 2003-08-06
CA2419064A1 (en) 2002-02-14
WO2002012894A9 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU1309599A (en) Signal peptide-containing proteins
HK1028773A1 (en) Interleukin-18 binding proteins, their preparationand use
AU6059699A (en) Synthetic peptides, conjugation reagents and methods
AU1606800A (en) Membrane transport proteins
AU2462399A (en) Cubilin protein, dna sequences encoding cubilin and uses thereof
IL147637A0 (en) Sequence based screening
AU1178100A (en) Novel g protein-coupled receptor protein, its dna and ligand thereof
AU2001284790A1 (en) Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein
AU1744900A (en) Gtpase associated proteins
AU4432901A (en) Alpha 7 nicotinic receptor screening assays
AU5150499A (en) Rationally designed peptides, production and use thereof
HUP0202270A3 (en) Antitumor antibodies, proteins, and uses thereof
AU3254799A (en) Sorting wc-accession
AU6260399A (en) Membrane-associated organizational proteins
AU1458600A (en) Transmembrane 4 proteins
AU2001241880A1 (en) 2504, 15977, and 14760, novel protein kinase family members and uses therefor
EP1144629A3 (en) Further pro polypeptides and sequences thereof
GB9827845D0 (en) Immunoassay or proteins
AUPP460498A0 (en) Modified proteins
AU2001270075A1 (en) 58199, a membrane-associated protein and uses therefor
AU6040798A (en) Novel proline-rich membrane protein
AU9537901A (en) A novel polypeptide - human oxysterol-binding protein 38.72 and a polynucleotideencoding the same
AU2001227925A1 (en) Odorant receptor polypeptides and nucleic acids encoding same
AU2001259156A1 (en) Novel membrane proteins and polynucleotides encoding the same